301408 华人健康
交易中 09-01 14:21:24
资讯
新帖
简况
闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬
市场资讯 · 08-31 12:41
闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬
华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-29
华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升
华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%
证券之星 · 08-28
华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%
华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%
证券之星 · 08-28
华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%
股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》
证券之星 · 08-28
股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》
图解华人健康中报：第二季度单季净利润同比增长33.03%
证券之星 · 08-28
图解华人健康中报：第二季度单季净利润同比增长33.03%
华人健康：医药营销板块已实现落地应用
证券之星 · 08-18
华人健康：医药营销板块已实现落地应用
华人健康：代理奥利司他胶囊、排毒清脂胶囊
证券之星 · 08-18
华人健康：代理奥利司他胶囊、排毒清脂胶囊
华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场
新浪证券 · 08-14
华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场
华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态
证券之星 · 08-12
华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态
股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》
证券之星 · 08-12
股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》
华人健康：AI技术主要应用于门店运营领域
证券之星 · 08-11
华人健康：AI技术主要应用于门店运营领域
华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%
证券之星 · 08-11
华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%
华人健康：持续践行仿创结合的研发战略
证券之星 · 08-11
华人健康：持续践行仿创结合的研发战略
华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目
证券之星 · 08-10
华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目
华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金
美股速递 · 08-10
华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金
股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》
证券之星 · 08-10
股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》
华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理
格隆汇 · 08-09
华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理
华人健康新提交“鸿方”、“固恒健”等2件商标注册申请
证券之星 · 08-07
华人健康新提交“鸿方”、“固恒健”等2件商标注册申请
华人健康：公司管理层始终立足长期经营，持续看好医药主业长远发展
证券之星 · 07-31
华人健康：公司管理层始终立足长期经营，持续看好医药主业长远发展
加载更多
公司概况
公司名称：
安徽华人健康医药股份有限公司
所属行业：
零售业
上市日期：
2023-03-01
主营业务：
安徽华人健康医药股份有限公司的主营业务是医药零售、医药营销、终端集采、研发生产。公司的主要产品是中西成药、中药饮片、保健品、医疗器械、原料药。
发行价格：
16.24
{"stockData":{"symbol":"301408","market":"SZ","secType":"STK","nameCN":"华人健康","latestPrice":14.89,"timestamp":1788243684000,"preClose":14.67,"halted":0,"volume":7306637,"delay":0,"changeRate":0.015,"floatShares":229000000,"shares":400000000,"eps":0.5588,"marketStatus":"交易中","change":0.22,"latestTime":"09-01 14:21:24","open":14.56,"high":15.03,"low":14.56,"amount":109000000,"amplitude":0.032,"askPrice":14.89,"askSize":115,"bidPrice":14.88,"bidSize":131,"shortable":0,"etf":0,"ttmEps":0.5588,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788246000000},"marketStatusCode":2,"adr":0,"adjPreClose":14.67,"symbolType":"stock","openAndCloseTimeList":[[1788226200000,1788233400000],[1788238800000,1788246000000]],"highLimit":16.14,"lowLimit":13.2,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400010000,"isCdr":false,"pbRate":2.77,"roa":"--","peRate":26.646385,"roe":"6.31%","epsLYR":0.48,"committee":0.098008,"marketValue":5956000000,"turnoverRate":0.0319,"status":0,"floatMarketCap":3409000000},"requestUrl":"/m/hq/s/301408/","defaultTab":"news","newsList":[{"id":"2663246020","title":"闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬","url":"https://stock-news.laohu8.com/highlight/detail?id=2663246020","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663246020?lang=zh_cn&edition=full","pubTime":"2026-08-31 12:41","pubTimestamp":1788151260,"startTime":"0","endTime":"0","summary":"值得关注的是，在推进新一轮股权融资的当下，华人健康IPO阶段募集资金并未完全消耗。募投两度改道据了解，华人健康IPO阶段，将自建直营门店作为营销网络建设项目的核心路径。回到华人健康这一个案，本次7.09亿元定增方案推出之时，IPO募集资金尚有结余，同时方案设置1.5亿元补充流动资金，市场由此关注本次再融资的资金必要性。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-31/doc-iniqetnt4650485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301408","FRHC","BK4127","REDS","KCE","BK0209","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016225","title":"华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016225?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:52","pubTimestamp":1787957558,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华人健康发布2026年中报。截至本报告期末，公司营业总收入28.25亿元，同比上升12.81%，归母净利润1.36亿元，同比上升31.01%。本报告期华人健康盈利能力上升，毛利率同比增幅3.89%，净利率同比增幅17.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062719","title":"华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662062719?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:13","pubTimestamp":1787915637,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华人健康报收于14.88元，较前一交易日下跌1.33%，最新总市值为59.52亿元。报告期内，公司实现营业收入2,824,690,091.29元，同比增长12.81%；归属于上市公司股东的净利润为135,908,900.86元，同比增长31.01%；扣除非经常性损益后的净利润为132,056,760.71元，同比增长31.00%。报告期末，公司总资产为5,468,260,909.33元，较上年度末下降0.37%；归属于上市公司股东的净资产为2,118,892,308.38元，较上年度末增长1.05%。公司控股股东及实际控制人在报告期内未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800044674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662606951","title":"华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662606951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662606951?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:57","pubTimestamp":1787911046,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华人健康披露，截至2026年7月20日公司股东户数为3.22万户，较6月30日增加3098.0户，增幅为10.64%。在医药商业行业个股中，华人健康股东户数低于行业平均水平，截至7月20日，医药商业行业平均股东户数为4.45万户。从股价来看，2026年6月30日至2026年7月20日，华人健康区间涨幅为3.48%，在此期间股东户数增加3098.0户，增幅为10.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603550","title":"股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662603550?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:08","pubTimestamp":1787864895,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司自2026年1月1日起执行《企业会计准则解释第20号》，本次会计政策变更无需提交董事会和股东会审议，不产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662851080","title":"图解华人健康中报：第二季度单季净利润同比增长33.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662851080","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662851080?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:04","pubTimestamp":1787857443,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康2026年中报显示，上半年度公司主营收入28.25亿元，同比上升12.81%；归母净利润1.36亿元，同比上升31.01%；扣非净利润1.32亿元，同比上升31.0%；其中2026年第二季度，公司单季度主营收入14.04亿元，同比上升13.47%；单季度归母净利润5656.54万元，同比上升33.03%；单季度扣非净利润5414.98万元，同比上升31.73%；负债率60.25%，投资收益169.84万元，财务费用1530.01万元，毛利率34.72%。财报数据概要请见下图:本文数据来源于华人健康2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660671714","title":"华人健康：医药营销板块已实现落地应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2660671714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660671714?lang=zh_cn&edition=full","pubTime":"2026-08-18 20:51","pubTimestamp":1787057492,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康08月17日在投资者关系平台上答复投资者关心的问题。医药营销板块已实现落地应用，上线商城智能推荐系统，依托算法实现商品精准推送，提升转化效率；终端集采板块相关 AI 应用正在布局推进中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800039883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK1515","BK1161","09939","159938","301408","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660538474","title":"华人健康：代理奥利司他胶囊、排毒清脂胶囊","url":"https://stock-news.laohu8.com/highlight/detail?id=2660538474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660538474?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:36","pubTimestamp":1787013371,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康(301408)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：华人健康有代理减肥药销售吗？华人健康回复：尊敬的投资者，您好！公司代理业务板块相关减重产品有奥利司他胶囊、排毒清脂胶囊。买药、用药请遵医嘱或咨询执业医师、执业药师。上述药品销售预计不会对公司业绩产生重大影响。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800007370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659197145","title":"华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场","url":"https://stock-news.laohu8.com/highlight/detail?id=2659197145","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659197145?lang=zh_cn&edition=full","pubTime":"2026-08-14 12:03","pubTimestamp":1786680180,"startTime":"0","endTime":"0","summary":"华人健康未来能否持续抵御行业性毛利率下滑压力，仍有待观察。2025年阿里健康实施大额减持，套现规模约1.2亿元，持股比例降至5%以下，后续减持无需持续公告。赛富投资旗下多家机构同样密集减持。截至2026年4月末，赛富投资已累计减持400万股。华泰紫金旗下华泰大健康一号基金减持力度更大。2026年一季度，华泰大健康一号基金已退出前十大股东名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-08-14/doc-ininhaiq4219507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["REDS","BK0209","FRHC","301408","BK4127","KCE","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658500924","title":"华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2658500924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658500924?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:03","pubTimestamp":1786518195,"startTime":"0","endTime":"0","summary":"公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态，持续深化工业端产品与终端渠道协同发展。门诊统筹、商保直付是零售药店重要发展方向，公司持续推动符合条件的门店完成资质对接与业务开通，稳步拓展门店覆盖范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200020331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0209","301408","BK1574","BK1161","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391252","title":"股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658391252?lang=zh_cn&edition=full","pubTime":"2026-08-12 00:58","pubTimestamp":1786467490,"startTime":"0","endTime":"0","summary":"利润分配方案需经董事会审议后提交股东大会通过。关于本次向特定对象发行A股股票预案披露的提示性公告安徽华人健康医药股份有限公司于2026年8月10日召开第五届董事会第十五次会议，审议通过了关于公司2026年度向特定对象发行A股股票的相关议案。本次发行事项尚需经公司股东大会审议、深圳证券交易所审核及中国证监会注册，公告提示该事项未构成实质性判断或批准，提醒投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658286918","title":"华人健康：AI技术主要应用于门店运营领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2658286918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658286918?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:48","pubTimestamp":1786452501,"startTime":"0","endTime":"0","summary":"公司目前 AI 技术主要应用于门店运营领域，正规划有关医药零售、智能审方、供应链管理等业务场景，由数字化到数智化转型升级落地；同时在药品研发环节引入 AI 赋能，如立项阶段智能分析流行病、临床及专利数据，研判市场格局并提供专利规避思路；开发阶段辅助制剂处方工艺设计，同步评估技术壁垒等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100035597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996991","title":"华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996991","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996991?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:26","pubTimestamp":1786440414,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，华人健康报收于16.3元，较前一交易日上涨2.77%，最新总市值为65.2亿元。该股当日开盘15.56元，最高17.3元，最低15.55元，成交额达6.29亿元，换手率为16.66%。近日，安徽华人健康医药股份有限公司披露《2026年度向特定对象发行A股股票预案》，拟向特定对象发行A股股票，募集资金总额不超过70,907.43万元，用于智能制造与分拣中心项目、医药研发项目、信息化建设项目及补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","301408","BK0209","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658872995","title":"华人健康：持续践行仿创结合的研发战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2658872995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658872995?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:36","pubTimestamp":1786437375,"startTime":"0","endTime":"0","summary":"仿制药与创新药之间的资源分配优先级是怎样的？公司持续践行仿创结合的研发战略，不断优化研发管线结构，立足于中长期发展规划，积极布局改良型新药、创新药及生物药领域，稳步优化管线结构、提升创新类品种占比，并依托正药科技、神华药业推进研发协同。公司实施梯队化管线布局，以高端及成熟仿制药夯实经营基本盘，保障产品持续落地与现金流转化；同步培育改良型新药、创新药、生物药，打造中长期增长动力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100026012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658093954","title":"华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2658093954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658093954?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:40","pubTimestamp":1786365651,"startTime":"0","endTime":"0","summary":"华人健康(301408.SZ)公告称，公司发布2026年度向特定对象发行A股股票预案，拟向不超过35名特定对象发行股票，数量不超过5000万股，募集资金总额不超过7.09亿元，用于智能制造与分拣中心项目、医药研发项目、信息化建设项目及补充流动资金。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000030931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179716724","title":"华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1179716724","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179716724?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:29","pubTimestamp":1786364955,"startTime":"0","endTime":"0","summary":"华人健康（Anhui Huaren Health Pharmaceutical Co., Ltd.）近日宣布，公司计划通过A股非公开发行方式募集资金，总额上限为7.091亿元人民币。这笔资金将主要用于支持公司旗下项目的推进，并补充日常运营所需的资本金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658702616","title":"股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658702616","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658702616?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:43","pubTimestamp":1786297389,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，华人健康报收于15.54元，上涨2.71%，换手率13.59%，成交量31.13万手，成交额4.77亿元。该药品为抗贫血药物，适用于治疗和预防成人、儿童及孕妇的缺铁性贫血。本次注册申请已获受理，进入审评阶段，但审批结果、获批时间及后续销售情况存在不确定性，对公司短期业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658743146","title":"华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658743146","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658743146?lang=zh_cn&edition=full","pubTime":"2026-08-09 16:15","pubTimestamp":1786263304,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612676","title":"华人健康新提交“鸿方”、“固恒健”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657612676?lang=zh_cn&edition=full","pubTime":"2026-08-07 07:08","pubTimestamp":1786057707,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日安徽华人健康医药股份有限公司新提交“鸿方”、“固恒健”等2件商标注册申请。商标申请详情如下：今年以来安徽华人健康医药股份有限公司新申请注册商标102件，截止目前公司共持有注册商标281件，另有154件商标尚在注册申请中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700006109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655387798","title":"华人健康：公司管理层始终立足长期经营，持续看好医药主业长远发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2655387798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655387798?lang=zh_cn&edition=full","pubTime":"2026-07-31 08:27","pubTimestamp":1785457629,"startTime":"0","endTime":"0","summary":"贵公司股票股价已经跌破发行价，并且，相对于2026年1月14日的高点收盘价29.66元，目前价格在13.80元，已经跌了53%，已经腰斩！请问，贵公司懂事们是否还继续看好公司的发展？公司管理层、董事会成员始终立足长期经营，持续看好医药主业长远发展，专注推进药品研发、产品落地、市场拓展、精细化运营等核心经营工作，扎实夯实公司基本面，以稳定可持续的经营成果回馈全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100006942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK1574","159938","BK1515","BK1161","09939","301408"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788243687890,"stockEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":0.0375},{"period":"3month","weight":-0.1535},{"period":"6month","weight":-0.1828},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.2048}],"compareEarnings":[{"period":"1week","weight":0.0269},{"period":"1month","weight":0.0402},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0236},{"period":"1year","weight":0.0333},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华人健康医药股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"32225人(较上一季度增加10.64%)","perCapita":"7105股","listingDate":"2023-03-01","address":"安徽省合肥市包河区河北路123号","registeredCapital":"40001万元","survey":" 安徽华人健康医药股份有限公司的主营业务是医药零售、医药营销、终端集采、研发生产。公司的主要产品是中西成药、中药饮片、保健品、医疗器械、原料药。","listedPrice":16.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华人健康,301408,华人健康股票,华人健康股票老虎,华人健康股票老虎国际,华人健康行情,华人健康股票行情,华人健康股价,华人健康股市,华人健康股票价格,华人健康股票交易,华人健康股票购买,华人健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}